162 related articles for article (PubMed ID: 37199104)
1. Steno-sphere: Navigating the enigmatic world of emerging multidrug-resistant Stenotrophomonas maltophilia.
Kunz Coyne AJ; Herbin S; Caniff K; Rybak MJ
Pharmacotherapy; 2023 Aug; 43(8):833-846. PubMed ID: 37199104
[TBL] [Abstract][Full Text] [Related]
2. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
[TBL] [Abstract][Full Text] [Related]
3. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
[No Abstract] [Full Text] [Related]
4. Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis.
Lee YL; Hsueh PR
Curr Opin Infect Dis; 2023 Dec; 36(6):481-494. PubMed ID: 37548375
[TBL] [Abstract][Full Text] [Related]
5. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
Wu RX; Yu CM; Hsu ST; Wang CH
J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
Lee YL; Liu CE; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2023 Aug; 62(2):106878. PubMed ID: 37285926
[TBL] [Abstract][Full Text] [Related]
7. Clinical and microbiological characteristics of patients colonized or infected by Stenotrophomonas maltophilia : is resistance to sulfamethoxazole/trimethoprim a problem?
Mendes ET; Paez JIG; Ferraz JR; Marchi AP; Silva ILAFE; Batista MV; Lima ALM; Rossi F; Levin AS; Costa SF
Rev Inst Med Trop Sao Paulo; 2020; 62():e96. PubMed ID: 33295480
[TBL] [Abstract][Full Text] [Related]
8. Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis.
Bostanghadiri N; Sholeh M; Navidifar T; Dadgar-Zankbar L; Elahi Z; van Belkum A; Darban-Sarokhalil D
Ann Clin Microbiol Antimicrob; 2024 Mar; 23(1):26. PubMed ID: 38504262
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.
Junco SJ; Bowman MC; Turner RB
Int J Antimicrob Agents; 2021 Aug; 58(2):106367. PubMed ID: 34058337
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Doxycycline or Minocycline to Sulfamethoxazole-Trimethoprim for Treatment of
Alhayani T; Philpott CD; Liao S; Gentene AJ; Mueller EW
Ann Pharmacother; 2024 Jan; 58(1):21-27. PubMed ID: 37125743
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Activity of Aztreonam-Avibactam and Comparator Agents When Tested against a Large Collection of Contemporary Stenotrophomonas maltophilia Isolates from Medical Centers Worldwide.
Sader HS; Duncan LR; Arends SJR; Carvalhaes CG; Castanheira M
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32900683
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
13. Trends in
Appaneal HJ; Lopes VV; LaPlante KL; Caffrey AR
J Med Microbiol; 2022 Oct; 71(10):. PubMed ID: 36306237
[No Abstract] [Full Text] [Related]
14.
Nakamura R; Oota M; Matsumoto S; Sato T; Yamano Y
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526491
[TBL] [Abstract][Full Text] [Related]
15. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
Hand E; Davis H; Kim T; Duhon B
J Antimicrob Chemother; 2016 Apr; 71(4):1071-5. PubMed ID: 26801080
[TBL] [Abstract][Full Text] [Related]
16. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
Kaur P; Gautam V; Tewari R
Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206
[TBL] [Abstract][Full Text] [Related]
17. Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.
Mojica MF; Rutter JD; Taracila M; Abriata LA; Fouts DE; Papp-Wallace KM; Walsh TJ; LiPuma JJ; Vila AJ; Bonomo RA
mBio; 2019 Jul; 10(4):. PubMed ID: 31266860
[No Abstract] [Full Text] [Related]
18. Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits.
Petraitis V; Petraitiene R; Kavaliauskas P; Naing E; Garcia A; Georgiades BN; Echols R; Bonomo RA; Yamano Y; Satlin MJ; Walsh TJ
Antimicrob Agents Chemother; 2022 Oct; 66(10):e0061822. PubMed ID: 36154614
[TBL] [Abstract][Full Text] [Related]
19.
Flamm RK; Shortridge D; Castanheira M; Sader HS; Pfaller MA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427295
[TBL] [Abstract][Full Text] [Related]
20. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
